DIA Biosimilars 2013

Clinphone

Icon acquires Firecrest Clinical, adding portal technology to boost site quality while reducing errors and costs

Monday, July 25, 2011 08:02 AM

As large pharmaceutical companies scrutinize the pack of mid- and top-tier CROs to determine who wins the coveted strategic-partnership agreements, there’s a mad scramble among CROs to differentiate themselves from one another and stand out as efficient, high quality, exciting and deserving.

More... »

Cenduit: Now with Patient Reminders

Todd Kole appointed to Almac’s clinical tech team

Friday, May 6, 2011 12:41 PM

Almac’s clinical technologies business unit has appointed Todd Kole as vice president of clinical project services (CPS) and a member of the executive leadership team.  He will oversee clinical project management and drug supply services globally.

More... »

CRF Health – eCOA Forum

Accounting Errors Cost Parexel in Fourth Quarter, Fiscal Year

Tuesday, August 11, 2009 07:13 AM

Parexel’s fourth-quarter revenue and income took a significant hit due to accounting errors related to the August 2008 acquisition of clinical trials technology company Clinphone, according to the contract research organization’s (CRO’s) financial results released last night.

More... »

Parexel Completes ClinPhone Acquisition and Cuts Earnings Guidance

Tuesday, September 9, 2008 09:41 AM

Parexel, a global contract research organization (CRO), cut its earnings guidance for its first quarter of fiscal year 2009 and for the full fiscal year, with the successful completion of its acquisition of eClinical trial technology company ClinPhone for about $182 million.

More... »

Parexel Finalizes ClinPhone Acquisition

Thursday, August 14, 2008 02:56 PM

Contract research organization (CRO) Parexel International has finalized the acquisition of UK-based clinical technology firm ClinPhone. ClinPhone and Perceptive Informatics, Parexel’s existing technology subsidiary, will combine to provide enhanced eClinical services and products, according to a Parexel statement released today.

More... »

Medidata Aspiring to Win Over CRO Market

Tuesday, July 8, 2008 06:05 AM

As the industry enters a period of eClinical consolidation — ClinPhone and Datalabs, PharmaLinkFHI and Matrix Contract Research, Parexel and Green Mountain Logic — and as the adoption of these technologies swells, not only has the playing field narrowed for these companies, but the game itself is changing.

More... »

Quintiles Will Not Pursue ClinPhone Acquisition, Parexel’s Offer Stands

Wednesday, July 2, 2008 12:47 PM

Durham, N.C.-based contract research organization (CRO) Quintiles stated it will not counter Waltham, Mass.-based rival CRO Parexel’s bid for the acquisition of ClinPhone, a clinical technology company based in the UK. Parexel’s offer is $182 million in cash, an 86% premium over ClinPhone's share price.

More... »

eClinical Market Has Strong Year

Monday, November 27, 2006 10:01 AM

In its third quarter, Morrisville, N.C.-based eClinical service provider etrials reported 40% growth in services revenue to $4.4 million.Net revenues during the same period in 2005 were $3.2 million. The company reported operating income of $178,331 compared with an operating loss of $148,618 in 2005 during the same period. etrials went public in 2005 in a reverse merger.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs